Log In
person
Bristol-Myers Squibb Co
BMY
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (USD) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (USD) | Percentage |
| BioPharma |
Branded Pharmaceuticals
These companies research, develop, and manufacture patented drugs.
|
43.78B | 97.27% |
| BioPharma |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
1.23B | 2.73% |
| keyboard_arrow_down |
BioPharma
Branded Pharmaceuticals
|
43.78B | 97.27% |
| keyboard_arrow_right |
These companies research, develop, and manufacture patented drugs.
|
||
| keyboard_arrow_down |
BioPharma
Pre-Revenue Pharmaceuticals
|
1.23B | 2.73% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||